1932

Abstract

Newborn screening (NBS) represents the largest volume of genetic testing. The 45-year history of NBS has demonstrated its benefits, as well as the importance of an evidence base. The recent addition of tandem mass spectrometry (MS/MS) resulted in a fivefold increase in the number of tests. Experience with MS/MS also showed that laboratory tests are just one part of the NBS system. The lessons learned from NBS will provide important insights as we move into the predictive, preventive, and personalized era of genomic medicine.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.med.59.110106.132016
2008-02-18
2024-04-20
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.med.59.110106.132016
Loading
/content/journals/10.1146/annurev.med.59.110106.132016
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error